FLT3 and acute myeloid leukemia: In summary, we propose a new midostaurin resistance mechanism in FLT3-mutated AML cells, in which actin cytoskeleton remodeling by FLT3-dependent RAC1 activation, N-WASP phosphorylation and ARP2/3 complex activation favors AML cell survival and proliferation.